Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRAETORIAN-COVID: A Double-blind, Placebo-controlled Randomized Clinical Trial With Valsartan for PRevention of Acute rEspiraTORy dIstress Syndrome in hospitAlized patieNts With SARS-COV-2 (COVID-19) Infection Disease

NCT04335786 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04335786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04335786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRAETORIAN-COVID: A Double-blind, Placebo-controlled Randomized Clinical Trial With Valsartan for PRevention of Acute rEspiraTORy dIstress Syndrome in hospitAlized patieNts With SARS-COV-2 (COVID-19) Infection Disease
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
April 17, 2020
Completion date
May 25, 2021
Enrollment
23 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid, covid-19, sars-cov-2, severe acute respiratory syndrome